schizandrin b has been researched along with fluorescein-5-isothiocyanate in 1 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (fluorescein-5-isothiocyanate) | Trials (fluorescein-5-isothiocyanate) | Recent Studies (post-2010) (fluorescein-5-isothiocyanate) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 8,493 | 33 | 2,090 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, PY; Ko, KM; Leung, HY; Luk, KF; Ng, KM | 1 |
1 other study(ies) available for schizandrin b and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and inhibit associated changes in Ca2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes.
Topics: Annexin A5; Apoptosis; Calcium; Caspase 3; Cell Hypoxia; Cell Line; Cyclooctanes; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glutathione; Humans; Lignans; Membrane Potentials; Mitochondria, Heart; Mitochondrial Membranes; Myocytes, Cardiac; Permeability; Poly(ADP-ribose) Polymerases; Polycyclic Compounds; Stereoisomerism | 2008 |